Adlai Nortye (ANL) Earnings Date & Reports

Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ANL is expected to report earnings to fall 4.69% to -61 cents per share on May 29

Q1'24

Est.

$-0.61

Q4'24

Missed

by $0.01

Q2'24

Beat

by $0.26

Q4'23

Est.

$-0.38

Q3'23

Est.

$-0.24

The last earnings report on April 30 showed earnings per share of -63 cents, missing the estimate of -62 cents. With 1.68K shares outstanding, the current market capitalization sits at 57.20M.

View a ticker or compare two or three

Compare

ANL